Report #2899748

Received Jun 11, 2026

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Unknown
Age: Age unknown
State: CT
Recovered: Unknown
Vaccinated: —
Onset: —
Days to onset: —
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
VARZOS	ZOSTER (SHINGRIX)	GLAXOSMITHKLINE BIOLOGICALS	1	UNK	—

Symptoms (1)

Respiratory disorder

Symptom narrative

Experiencing respiratory issues; This non-serious case was reported by a consumer via call center representative and described the occurrence of respiratory disorder in a patient who received Herpes zoster (Shingrix) for prophylaxis. The patient's past medical history included pneumonia (have had pneumonia in the past). On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced respiratory disorder (Verbatim: Experiencing respiratory issues). The outcome of the respiratory disorder was not reported. It was unknown if the reporter considered the respiratory disorder to be related to Shingrix. Additional Information: GSK Receipt Date:05-JUN-2026 The patient is concerned about Guillan Barre and enquiring whether the second dose is advisable or not. The batch number was not provided and a request for this information has been made.

Medical history

Medical History/Concurrent Conditions: Pneumonia (have had pneumonia in the past)